Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.
Meet Our LeadersCompany Profile
Latest Presentation
Corporate Presentation
View This PresentationIndustry Classifications
Sector
Healthcare
Industry
Biotechnology
NAICS
All Other Basic Organic Chemical Manufacturing (325199)
SIC
Pharmaceutical Preparations (2834)
Investor Contacts
COMPANY
Immunovant, Inc.
320 W 37th Street
6th Floor
New York, NY 10018
INVESTOR RELATIONS
Immunovant, Inc.
Chau Cheng, Ph.D., M.B.A.
Investor Relations
info@immunovant.com
TRANSFER AGENT
Continental Stock Transfer & Trust Company, LLC
1 State Street
30th Floor
New York, NY 10004
T: 212-509-4000
cstmail@continentalstock.com